dc.contributor.author | Årdal, Christine Oline | |
dc.contributor.author | Baraldi, Enrico | |
dc.contributor.author | Theuretzbacher, Ursula | |
dc.contributor.author | Outterson, Kevin | |
dc.contributor.author | Plahte, Jens | |
dc.contributor.author | Ciabuschi, Francesco | |
dc.contributor.author | Røttingen, John-Arne | |
dc.date.accessioned | 2021-05-28T10:22:15Z | |
dc.date.available | 2021-05-28T10:22:15Z | |
dc.date.created | 2018-07-03T11:47:19Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Journal of Pharmaceutical Policy and Practice. 2018, 11 . | |
dc.identifier.issn | 2052-3211 | |
dc.identifier.uri | https://hdl.handle.net/11250/2756840 | |
dc.language.iso | eng | |
dc.relation.uri | https://joppp.biomedcentral.com/track/pdf/10.1186/s40545-018-0135-0 | |
dc.title | Insights into early stage of antibiotic development in small- and medium-sized enterprises: A survey of targets, costs, and durations | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.description.version | publishedVersion | |
dc.source.pagenumber | 10 | |
dc.source.volume | 11 | |
dc.source.journal | Journal of Pharmaceutical Policy and Practice | |
dc.identifier.doi | 10.1186/s40545-018-0135-0 | |
dc.identifier.cristin | 1595394 | |
cristin.unitcode | 7502,4,13,0 | |
cristin.unitcode | 7502,0,0,0 | |
cristin.unitname | Avdeling for resistens- og infeksjonsforebygging | |
cristin.unitname | Folkehelseinstituttet | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |